2023 - Research.com Medicine in Italy Leader Award
Vincenzo Di Marzo spends much of his time researching Endocannabinoid system, Cannabinoid receptor, Cannabinoid, Anandamide and Internal medicine. His Endocannabinoid system study is related to the wider topic of Receptor. His study focuses on the intersection of Cannabinoid receptor and fields such as Cancer research with connections in the field of Metastasis and Cancer cell.
His Cannabinoid research includes elements of AM404, TRPV1, Mechanism of action, Cannabinoid receptor type 2 and Stimulation. His Anandamide research includes themes of Oleamide, Palmitoylethanolamide, Fatty acid amide hydrolase and Cell biology. His work in Internal medicine covers topics such as Endocrinology which are related to areas like Trk receptor.
His main research concerns Endocannabinoid system, Cannabinoid receptor, Cannabinoid, Internal medicine and Anandamide. His Endocannabinoid system research is multidisciplinary, incorporating elements of Palmitoylethanolamide, Neuroscience and Pharmacology. Many of his studies on Cannabinoid receptor apply to Cell biology as well.
The Cannabinoid study combines topics in areas such as Cannabinoid Receptor Modulators, TRPV1, Cannabidiol, Inverse agonist and Stereochemistry. Internal medicine is closely attributed to Endocrinology in his study. His Anandamide course of study focuses on Fatty acid amide hydrolase and Monoacylglycerol lipase.
His scientific interests lie mostly in Endocannabinoid system, Internal medicine, Endocrinology, Cannabinoid receptor and Pharmacology. His Endocannabinoid system research also works with subjects such as
The concepts of his Cannabinoid receptor study are interwoven with issues in Inverse agonist, Cannabinoid and Cell biology. He usually deals with Cannabinoid and limits it to topics linked to Cannabidiol and Epilepsy. Vincenzo Di Marzo studied Pharmacology and Palmitoylethanolamide that intersect with Oleoylethanolamide.
Vincenzo Di Marzo mainly investigates Endocannabinoid system, Endocrinology, Internal medicine, Pharmacology and Receptor. His Endocannabinoid system study incorporates themes from Microbiome, Bioinformatics, Microglia, Cannabinoid receptor and Neuroscience. Vincenzo Di Marzo has researched Cannabinoid receptor in several fields, including Haloperidol, Quantitative structure–activity relationship, Cannabinoid and Monoacylglycerol lipase.
Vincenzo Di Marzo interconnects Anandamide, Gut flora and Phthalate in the investigation of issues within Endocrinology. His work carried out in the field of Pharmacology brings together such families of science as Inflammation, Nicotine withdrawal, Nicotine, Cannabinoid receptor type 2 and Palmitoylethanolamide. His studies deal with areas such as In silico and Cell biology as well as Receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Peter M. Zygmunt;Jesper Petersson;David A. Andersson;Huai Hu Chuang.
The endogenous cannabinoid system controls extinction of aversive memories
Giovanni Marsicano;Carsten T. Wotjak;Shahnaz C. Azad;Shahnaz C. Azad;Tiziana Bisogno.
Leptin-regulated endocannabinoids are involved in maintaining food intake
Vincenzo Di Marzo;Sravan K. Goparaju;Lei Wang;Lei Wang;Jie Liu;Jie Liu.
Identification and Functional Characterization of Brainstem Cannabinoid CB2 Receptors
Marja D. Van Sickle;Marnie Duncan;Philip J. Kingsley;Abdeslam Mouihate.
The endocannabinoid system and its therapeutic exploitation
Vincenzo Di Marzo;Maurizio Bifulco;Luciano De Petrocellis.
Nature Reviews Drug Discovery (2004)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity.
Giovanni Marsicano;Sharon Goodenough;Sharon Goodenough;Krisztina Monory;Heike Hermann.
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
Susan M. Huang;Tiziana Bisogno;Marcello Trevisani;Abdulmonem Al-Hayani.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
Tiziana Bisogno;Fiona Howell;Gareth Williams;Alberto Minassi.
Journal of Cell Biology (2003)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
Tiziana Bisogno;Lumír Hanuš;Luciano De Petrocellis;Susanna Tchilibon.
British Journal of Pharmacology (2001)
Endocannabinoid control of food intake and energy balance
Vincenzo Di Marzo;Isabel Matias.
Nature Neuroscience (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: